Citations 1
Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions
Yu, Jovian , Shukla, Navika , Treitman, Rachel, Haverkos, Bradley M. , Babcook, Melissa A., Carlson, Sophie G. , Gaut, Daria , Oliai, Caspian , Winter, Allison , Hill, Brian T. , Bansal, Radhika , Nizamuddin, Imran , Fitzgerald, Lindsey , Singh, Nathan , Bishop, Michael, Major, Ajay , Kamdar, Manali , Godfrey, James , Voorhees, Timothy , Oliai, Caspian H , Romancik, Jason T. , Villasboas, José C. , Karmali, Reem , Stephens, Deborah M. , Pophali, Priyanka A. , Trabolsi, Asaad , Schatz, Jonathan H , Hu, Marie , Bachanová, Veronika , Slade, Michael , Singh, Nathan , Ahmed, Nausheen , McGuirk, Joseph P. , Riedell, Peter A. , Kline, Justin Paul
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1328-1331
